Refinement of the Lugano Classification lymphoma response criteria in the era of immunomodulatory therapy

Bruce D. Cheson, Stephen Ansell, Larry Schwartz, Leo I. Gordon, Ranjana Advani, Heather A. Jacene, Axel Hoos, Sally F. Barrington and Philippe Armand

Article Information

vol. 128 no. 21 2489-2496

Print ISSN 
Online ISSN 
  • Submitted May 24, 2016
  • Accepted August 16, 2016
  • Published online November 24, 2016.

Article Versions

  • Bruce D. Cheson, 1Division of Hematology-Oncology, Department of Medicine, Lombardi Comprehensive Cancer Center, Georgetown University Hospital, Washington, DC;
  • Stephen Ansell, 2Division of Hematology, Mayo Clinic, Rochester, MN;
  • Larry Schwartz, 3Department of Radiology, New York Presbyterian Hospital, Columbia University College of Physicians and Surgeons, New York, NY;
  • Leo I. Gordon, 4Division of Hematology-Oncology, Department of Medicine, Northwestern University Feinberg School of Medicine and the Robert H. Lurie Comprehensive Cancer Center, Chicago, IL;
  • Ranjana Advani, 5Department of Medicine/Oncology, Stanford University, Stanford, CA;
  • Heather A. Jacene, 6Department of Imaging, Dana-Farber Cancer Institute, Boston, MA;
  • Axel Hoos, 7Oncology R&D, GlaxoSmithKline, Collegeville, PA; and
  • Sally F. Barrington, 8Department of Nuclear Medicine, PET Imaging Centre at St. Thomas’, London, United Kingdom
  • Philippe Armand, 6Department of Imaging, Dana-Farber Cancer Institute, Boston, MA; Statistics

The Altmetric score is a weighted count of online attention designed to reflect the volume and reach of online engagement surrounding an individual research output